Göschwitzer Straße 40
07745 Jena, de
+49 (3641) 351-0
CyBio AG Plans Rights Issue in a Ratio of 3:1
The Company's share capital is to be increased through the issue of up to 1,800,000 new no-per value bearer shares at a price of €1.00 per share. The new shares will increase the total number of issued and outstanding CyBio shares from 5,400,000 to 7,200,000.
CyBio shareholders will be granted an indirect subscription right. Any shares not subscribed by shareholders will be submitted to major shareholder Analytik Jena AG.
The expected cash inflow of approximately €1.8 million will strengthen the equity base and will provide CyBio with flexibility to successfully complete the initiated restructuring measures.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.